Impact Biomedical Inc. Announcement Stock Activity/Pricing
Impact BioMedical (NYSE American: IBO) released a statement on March 21, 2025, addressing unusual market activity in its stock price. The company confirmed that there have been no material developments in its business operations beyond what has been previously disclosed to the public. The biotechnology company, which focuses on discovering, developing, and patenting innovative healthcare solutions, stated it is unaware of any other reasons that could explain the unusual trading activity in its shares.
Impact BioMedical (NYSE American: IBO) ha rilasciato una dichiarazione il 21 marzo 2025, riguardo a un'attività di mercato insolita nel prezzo delle sue azioni. L'azienda ha confermato che non ci sono stati sviluppi materiali nelle sue operazioni commerciali oltre a quanto già comunicato al pubblico. La società biotecnologica, che si concentra sulla scoperta, sviluppo e brevetto di soluzioni sanitarie innovative, ha dichiarato di non essere a conoscenza di altre ragioni che possano spiegare l'attività di trading insolita delle sue azioni.
Impact BioMedical (NYSE American: IBO) emitió un comunicado el 21 de marzo de 2025, abordando una actividad de mercado inusual en el precio de sus acciones. La empresa confirmó que no ha habido desarrollos materiales en sus operaciones comerciales más allá de lo que se ha divulgado previamente al público. La compañía biotecnológica, que se centra en descubrir, desarrollar y patentar soluciones innovadoras de atención médica, afirmó que no tiene conocimiento de otras razones que puedan explicar la inusual actividad de negociación en sus acciones.
Impact BioMedical (NYSE American: IBO)는 2025년 3월 21일 주가의 비정상적인 시장 활동에 대한 성명을 발표했습니다. 회사는 중대한 발전이 공개된 내용을 넘어서는 사업 운영에서 없다고 확인했습니다. 혁신적인 헬스케어 솔루션의 발견, 개발 및 특허를 중점적으로 하는 생명공학 회사는 주식의 비정상적인 거래 활동을 설명할 수 있는 다른 이유를 알지 못한다고 밝혔습니다.
Impact BioMedical (NYSE American: IBO) a publié une déclaration le 21 mars 2025, concernant une activité de marché inhabituelle dans le prix de ses actions. L'entreprise a confirmé qu'il n'y a eu aucun développement matériel dans ses opérations commerciales au-delà de ce qui a déjà été communiqué au public. La société biotechnologique, qui se concentre sur la découverte, le développement et le brevetage de solutions de santé innovantes, a déclaré qu'elle n'était au courant d'aucune autre raison pouvant expliquer l'activité de trading inhabituelle de ses actions.
Impact BioMedical (NYSE American: IBO) gab am 21. März 2025 eine Erklärung zu ungewöhnlichen Marktaktivitäten bei seinem Aktienkurs ab. Das Unternehmen bestätigte, dass es keine wesentlichen Entwicklungen in seinen Geschäftstätigkeiten gegeben hat, die über das hinausgehen, was bereits der Öffentlichkeit mitgeteilt wurde. Das Biotechnologieunternehmen, das sich auf die Entdeckung, Entwicklung und Patentierung innovativer Gesundheitslösungen konzentriert, erklärte, dass es sich keiner anderen Gründe bewusst ist, die die ungewöhnliche Handelsaktivität seiner Aktien erklären könnten.
- None.
- None.
HOUSTON, March 21, 2025 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare solutions, today announced that there has been no material development in its business affairs not previously disclosed or, to its knowledge, any other reason to account for the unusual market action regarding its share price.
About Impact BioMedical, Inc.:
Impact BioMedical Inc. (NYSE American: IBO) discovers, confirms, and patents unique science and technologies which can be developed into new offerings in biopharmaceuticals and consumer healthcare and wellness in collaboration with external partners through research, licensing, co-development, joint ventures, and other relationships.
Safe Harbor Disclosure:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are subject to risks and uncertainties that may cause actual results or events to differ materially from those projected. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date.
Investor Relations:
info@impactbiomedinc.com
FAQ
What caused the unusual stock price movement in Impact BioMedical (IBO) shares on March 21, 2025?
Has Impact BioMedical (IBO) disclosed any new business developments as of March 21, 2025?
What was Impact BioMedical's (IBO) response to the unusual trading activity?
Did Impact BioMedical (IBO) announce any changes to its business operations on March 21, 2025?
